Cargando…
Risk of hepatocellular carcinoma after hepatitis C virus cure
Hepatitis C virus (HCV) is a significant cause of hepatocellular carcinoma (HCC). The direct-acting antivirals marked a new era of HCV therapy and are associated with greater than 95% cure rate. Successful treatment of chronic hepatitis C greatly reduces the risk of HCC. A proportion of patients, es...
Autores principales: | Luna-Cuadros, Maria Alejandra, Chen, Hao-Wei, Hanif, Hira, Ali, Mukarram Jamat, Khan, Muzammil Muhammad, Lau, Daryl Tan-Yeung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793019/ https://www.ncbi.nlm.nih.gov/pubmed/35125821 http://dx.doi.org/10.3748/wjg.v28.i1.96 |
Ejemplares similares
-
Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma
por: Hanif, Hira, et al.
Publicado: (2022) -
The dilemma of cytomegalovirus and hepatitis B virus interaction
por: Khan, Muzammil M, et al.
Publicado: (2022) -
Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure
por: Shinn, Brianna J, et al.
Publicado: (2019) -
A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
por: Hanif, Hira, et al.
Publicado: (2020) -
Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection
por: Irshad, Mohammad, et al.
Publicado: (2017)